Evidence map›Paper›PMID 41160467›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Atrophy patterns of deep gray matter nuclei in Alzheimer's disease and frontotemporal dementia.

Arit Banerjee, Fan Yang, Joyita Dutta, Alberto Cacciola, Michael Hornberger, Manojkumar Saranathan

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Thalamic nuclei insights into Alzheimer's disease.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Implication of the thalamus in sleep alterations observed in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Arit BanerjeeDepartment of Biomedical Engineering, University of Massachusetts, Life Science Laboratories, Amherst, MA, USA.ORCID 0000-0001-6971-5846
Fan YangDepartment of Biomedical Engineering, University of Massachusetts, Life Science Laboratories, Amherst, MA, USA.
Joyita DuttaDepartment of Biomedical Engineering, University of Massachusetts, Life Science Laboratories, Amherst, MA, USA.
Alberto CacciolaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Michael HornbergerClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Manojkumar SaranathanDepartment of Biomedical Engineering, University of Massachusetts, Life Science Laboratories, Amherst, MA, USA.ORCID 0000-0001-9020-9948

Funding

The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Longitudinal predictive modeling for tau in Alzheimer's diseaseR01AG072669 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI DUTTA, JOYITA · 2021 to 2025
$2.7M
Next-Generation Thalamic Nuclei Visualization and Segmentation MethodsR01EB032674 · NIBIB · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Manojkumar Saranathan · 2022 to 2026
$1.8M
Super-Resolved Multimodal Imaging Biomarkers for Frontotemporal DementiaR21AG087392 · NIA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI DUTTA, JOYITA, SARANATHAN, MANOJKUMAR · 2024 to 2025
$474k
Super-Resolution Tau PET Imaging for Alzheimer's DiseaseR03AG070750 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI DUTTA, JOYITA · 2021 to 2022
$304k
NIA NIH HHS R01 AG032306NIA NIH HHS R01 AG072669NIA NIH HHS R03 AG070750NIA NIH HHS R21 AG087392NIBIB NIH HHS R01 EB032674
6 · The paper itself

Abstract

BackgroundWhile cortical atrophy has been widely studied in dementia, emerging evidence highlights the role of subcortical degeneration, particularly in deep gray matter structures such as the thalamus, claustrum, and basal nuclei, in both Alzheimer's disease (AD) and frontotemporal dementia (FTD). However, disease-specific subcortical patterns remain undercharacterized.ObjectiveTo quantify deep gray matter atrophy across the AD continuum (mild cognitive impairment and AD) and three FTD subtypes (bvFTD, svFTD, PNFA), and to assess longitudinal atrophy, cognitive associations, and diagnostic classification.MethodsWe applied a novel segmentation pipeline (sTHOMAS) to T1-weighted MRI data from 380 participants in the ADNI cohort and 274 participants in the FTLDNI cohort, with longitudinal follow-up available for 237 participants. Group differences were assessed using ANCOVA (adjusted for age and sex), followed by post hoc comparisons and effect size estimation (Cohen's d). Neuropsychological associations were examined using partial correlations. A hierarchical Random Forest model was trained to classify diagnostic groups.ResultsPronounced atrophy was observed in the mediodorsal, anteroventral, pulvinar thalamic nuclei, and nucleus accumbens, and claustrum in both AD and FTD, but was significantly greater in bvFTD. Longitudinal analysis revealed the fastest progression in bvFTD. Classification achieved 96.8% accuracy (AUC = 0.99) for AD versus FTD and 77.7% accuracy (AUC = 0.83) for PNFA versus svFTD. Subcortical atrophy correlated to executive, language, and semantic deficits.ConclusionsAtrophy in the mediodorsal, pulvinar, anteroventral thalamic nuclei, nucleus accumbens, and claustrum distinguishes AD from FTD and differentiates FTD subtypes. These subcortical structures represent promising biomarkers for diagnosis and monitoring of neurodegeneration.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaGray MatterAgedAged, 80 and overAtrophyCognitive DysfunctionCohort StudiesFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsAlzheimer's diseasedeep gray matter atrophyfrontotemporal dementiamild cognitive impairmentrandom forest classificationsubtype differentiationthalamic nuclei segmentation

Identifiers

PMID41160467
PMCPMC12638095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.